# KLF2

## Overview
KLF2, or Kruppel-like factor 2, is a gene that encodes the KLF transcription factor 2, a zinc finger protein that plays a pivotal role in regulating endothelial cell function and maintaining vascular homeostasis. As a transcription factor, KLF2 is involved in the modulation of gene expression critical for vascular tone, hemostasis, and inflammatory responses. It is activated by laminar shear stress and functions as a molecular switch to promote an anti-inflammatory and antithrombotic phenotype in endothelial cells. KLF2's regulatory activities include the induction of vasodilators and antithrombotic factors, while inhibiting vasoconstrictive and prothrombotic elements. The protein's interactions with various cellular components underscore its involvement in complex regulatory networks that influence vascular integrity and immune responses. Mutations in the KLF2 gene have been linked to several diseases, including certain lymphomas, immune deficiencies, and pulmonary arterial hypertension, highlighting its clinical significance (SenBanerjee2004KLF2; Novodvorsky2014The; Pernaa2022Heterozygous).

## Structure


## Function
KLF2 (KLF transcription factor 2) is a critical transcription factor involved in the regulation of endothelial cell function and vascular homeostasis. It plays a significant role in modulating the expression of genes that are essential for maintaining vascular tone, hemostasis, and inflammation. KLF2 induces the expression of vasodilators such as nitric oxide (NO) from endothelial nitric oxide synthase (eNOS) and C-natriuretic peptide (CNP), while inhibiting vasoconstrictive factors like endothelin-1 and angiotensin-converting enzyme (ACE) (Novodvorsky2014The). It also enhances the expression of antithrombotic factors such as thrombomodulin (TM) and tissue plasminogen activator (tPA), while reducing prothrombotic factors like plasminogen activator inhibitor-1 (PAI-1) and von Willebrand factor (vWF) (Novodvorsky2014The).

KLF2 is activated by laminar shear stress and acts as a molecular switch, promoting an anti-inflammatory and antithrombotic endothelial phenotype. It inhibits the expression of adhesion molecules such as VCAM-1 and E-selectin, reducing T-cell adhesion and rolling, which are critical in inflammatory responses (SenBanerjee2004KLF2). KLF2 also primes the antioxidant transcription factor Nrf2 for activation, enhancing the endothelial cells' antioxidative capacity and protecting against oxidative stress (Fledderus2008KLF2). These functions underscore KLF2's central role in maintaining vascular integrity and protecting against vascular diseases.

## Clinical Significance
Mutations and alterations in the KLF2 gene are associated with several diseases and conditions. A specific mutation, c.952dup, p.(Glu318Argfs*87), disrupts the zinc finger domain of KLF2, leading to dysregulated immune responses. This mutation is linked to malignancies such as splenic marginal zone B cell lymphoma (SMZL) and chronic lymphocytic leukemia (CLL), as well as immune abnormalities resembling common variable immunodeficiency (CVID) (Pernaa2022Heterozygous). Affected individuals often exhibit lymphopenia, low B and T cell counts, and altered Treg cell development, which may contribute to autoimmunity and conditions like juvenile idiopathic arthritis (Pernaa2022Heterozygous).

KLF2 is also implicated in pulmonary arterial hypertension (PAH), where reduced expression is associated with increased disease severity. A missense mutation in KLF2 has been identified in familial cases of PAH, suggesting compromised KLF2 signaling in the disease (Sindi2020Therapeutic). Additionally, KLF2 plays a role in inflammatory diseases such as rheumatoid arthritis and atherosclerosis, where its deficiency leads to increased inflammation and disease progression (Jha2017KLF2). KLF2's regulatory role in immune cell function and inflammation highlights its clinical significance in various pathological conditions (Jha2017KLF2).

## Interactions
KLF2 (KLF transcription factor 2) is known to interact with various proteins and nucleic acids, forming complexes that regulate gene expression and cellular processes. In mouse embryonic stem cells, KLF2 interacts with several proteins, including Crebbp, p300, Sfpq, and Nono, which are involved in transcriptional regulation. These interactions were identified using immunoprecipitation-mass spectrometry (IP-MS) (Seo2021Discovery). KLF2 also interacts with the oncoprotein Snd1, which acts as a transcriptional coactivator, particularly in the transcription of the Oct4 gene, suggesting a role in stem cell-specific gene expression (Seo2021Discovery).

In endothelial cells, KLF2 expression is regulated by tumor necrosis factor alpha (TNF-α) through interactions with NF-κB and histone deacetylases (HDACs). This regulation involves the formation of a trimolecular complex with MEF2C and p65, which inhibits KLF2 expression (Kumar2005Tumor). Additionally, KLF2 undergoes ubiquitination and degradation mediated by the E3-ubiquitin ligase WWP1, which reduces its transactivational ability (Zhang2004WWP1dependent).

KLF2's transcriptional regulation also involves interactions with heterogeneous nuclear ribonucleoproteins (hnRNPs) and acetyltransferases, such as PCAF and P300, which bind to its promoter region and modulate its expression (Ahmad2005Kruppellike). These interactions highlight the complex regulatory network in which KLF2 participates, influencing various biological processes.


## References


[1. (Seo2021Discovery) Lin Seo, Yong-In Kim, Hyoungmin Kim, Kwangbeom Hyun, Jaehoon Kim, and J. Eugene Lee. Discovery of klf2 interactors in mouse embryonic stem cells by immunoprecipitation-mass spectrometry utilizing exogenously expressed bait. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1869(9):140672, September 2021. URL: http://dx.doi.org/10.1016/j.bbapap.2021.140672, doi:10.1016/j.bbapap.2021.140672. This article has 3 citations.](https://doi.org/10.1016/j.bbapap.2021.140672)

[2. (Jha2017KLF2) Prerana Jha and Hiranmoy Das. Klf2 in regulation of nf-κb-mediated immune cell function and inflammation. International Journal of Molecular Sciences, 18(11):2383, November 2017. URL: http://dx.doi.org/10.3390/ijms18112383, doi:10.3390/ijms18112383. This article has 107 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms18112383)

[3. (Pernaa2022Heterozygous) Nora Pernaa, Salla Keskitalo, Iftekhar Chowdhury, Antti Nissinen, Virpi Glumoff, Riikka Keski-Filppula, Juhani Junttila, Kari K. Eklund, Wenny Santaniemi, Sanna Siitonen, Mikko RJ. Seppänen, Paula Vähäsalo, Markku Varjosalo, Pirjo Åström, and Timo Hautala. Heterozygous premature termination in zinc-finger domain of krüppel-like factor 2 gene associates with dysregulated immunity. Frontiers in Immunology, November 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.819929, doi:10.3389/fimmu.2022.819929. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.819929)

[4. (Fledderus2008KLF2) Joost O. Fledderus, Reinier A. Boon, Oscar L. Volger, Hanna Hurttila, Seppo Ylä-Herttuala, Hans Pannekoek, Anna-Liisa Levonen, and Anton J.G. Horrevoets. Klf2 primes the antioxidant transcription factor nrf2 for activation in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(7):1339–1346, July 2008. URL: http://dx.doi.org/10.1161/ATVBAHA.108.165811, doi:10.1161/atvbaha.108.165811. This article has 235 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1161/ATVBAHA.108.165811)

[5. (SenBanerjee2004KLF2) Sucharita SenBanerjee, Zhiyong Lin, G. Brandon Atkins, Daniel M. Greif, Ravi M. Rao, Ajay Kumar, Mark W. Feinberg, Zhiping Chen, Daniel I. Simon, F. William Luscinskas, Thomas M. Michel, Michael A. Gimbrone, Guillermo García-Cardeña, and Mukesh K. Jain. Klf2 is a novel transcriptional regulator of endothelial proinflammatory activation. The Journal of Experimental Medicine, 199(10):1305–1315, May 2004. URL: http://dx.doi.org/10.1084/jem.20031132, doi:10.1084/jem.20031132. This article has 586 citations.](https://doi.org/10.1084/jem.20031132)

[6. (Kumar2005Tumor) Ajay Kumar, Zhiyong Lin, Sucharita SenBanerjee, and Mukesh K. Jain. Tumor necrosis factor alpha-mediated reduction of klf2 is due to inhibition of mef2 by nf-κb and histone deacetylases. Molecular and Cellular Biology, 25(14):5893–5903, July 2005. URL: http://dx.doi.org/10.1128/mcb.25.14.5893-5903.2005, doi:10.1128/mcb.25.14.5893-5903.2005. This article has 134 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.25.14.5893-5903.2005)

[7. (Sindi2020Therapeutic) Hebah A. Sindi, Giusy Russomanno, Sandro Satta, Vahitha B. Abdul-Salam, Kyeong Beom Jo, Basma Qazi-Chaudhry, Alexander J. Ainscough, Robert Szulcek, Harm Jan Bogaard, Claire C. Morgan, Soni S. Pullamsetti, Mai M. Alzaydi, Christopher J. Rhodes, Roberto Piva, Christina A. Eichstaedt, Ekkehard Grünig, Martin R. Wilkins, and Beata Wojciak-Stothard. Therapeutic potential of klf2-induced exosomal micrornas in pulmonary hypertension. Nature Communications, March 2020. URL: http://dx.doi.org/10.1038/s41467-020-14966-x, doi:10.1038/s41467-020-14966-x. This article has 52 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-14966-x)

[8. (Zhang2004WWP1dependent) Xiaoling Zhang, Seetha V Srinivasan, and Jerry B Lingrel. Wwp1-dependent ubiquitination and degradation of the lung krüppel-like factor, klf2. Biochemical and Biophysical Research Communications, 316(1):139–148, March 2004. URL: http://dx.doi.org/10.1016/j.bbrc.2004.02.033, doi:10.1016/j.bbrc.2004.02.033. This article has 64 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2004.02.033)

[9. (Novodvorsky2014The) Peter Novodvorsky and Timothy J.A. Chico. The Role of the Transcription Factor KLF2 in Vascular Development and Disease, pages 155–188. Elsevier, 2014. URL: http://dx.doi.org/10.1016/b978-0-12-386930-2.00007-0, doi:10.1016/b978-0-12-386930-2.00007-0. This article has 87 citations.](https://doi.org/10.1016/b978-0-12-386930-2.00007-0)

[10. (Ahmad2005Kruppellike) Nisar Ahmad and Jerry B. Lingrel. Kruppel-like factor 2 transcriptional regulation involves heterogeneous nuclear ribonucleoproteins and acetyltransferases. Biochemistry, 44(16):6276–6285, April 2005. URL: http://dx.doi.org/10.1021/bi050018s, doi:10.1021/bi050018s. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi050018s)